Running notebook New cancer research benefit coming Oct. 6
New Drug Shows Promise in Breast Cancer Clinical Trials
For the past 22 years, the first Saturday in October has been reserved for the Houston Komen Race for the Cure. The city's largest walking and running event, it now draws more than 35,000 people ... read more..
New Drug Shows Promise in Breast Cancer Clinical Trials
A recent press release reports that the antibody-drug conjugate Trastuzumab Emtansine or T-DM1 has "significantly improved survival in the EMILIA Phase III Trial." This run of clinical trials was to establish the efficacy of T-DM1 in treating cases of metastatic HER-2 positive breast cancer. Patients enrolled on the trial had already been treated with taxane chemotherapy and Herceptin. read more..
source:http://www.scoopynews.com
